FilingReader Intelligence

Lupin transfers consumer healthcare business to subsidiary

June 30, 2025 at 07:04 PM UTC•By FilingReader AI

Lupin (BSE: LUPIN) announced the execution of a Business Transfer Agreement (BTA) effective today, June 30, 2025, to transfer its Over-the-Counter (OTC) Consumer Healthcare Business to LUPINLIFE Consumer Healthcare Limited (LCHL), a wholly-owned subsidiary. This strategic move, which follows earlier intimation letters on March 31 and April 30, 2025, involves a slump sale basis transfer, effective from July 1, 2025.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Execution of Business Transfer Agreement for transfer of its Over-the Counter Consumer Healthcare Business to LUPINLIFE Consumer Healthcare Limited, a wholly owned subsidiary of the Company, ....June 30, 2025 at 12:16 PM UTC

Supplementary Source Documents

Execution of Business Transfer Agreement for transfer of its API R&D Division situated at Pune, to Lupin Manufacturing Solutions Limited, a wholly owned subsidiary of the Company, on a ....June 30, 2025 at 01:07 PM UTC

Lupin

BSE:LUPIN•Bombay Stock Exchange

RSS feed for Lupin

News Alerts

Get instant email alerts when Lupin publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →